| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President &CEO
3 companies
Gujrathi Sheila serves as a President &CEO at GOSS and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 2 buys and 1 sell. Those positions are worth an estimated $301K at current prices.
The biggest single holding is VTYX (~$301K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 30,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2024 | VTYX Ventyx Biosciences, Inc. | Director | Buy | 130,000 | $2.31 | $300,573.00 | New | -42.1% | +286.0% | |
| Mar 30, 2023 | VTYX Ventyx Biosciences, Inc. | Director | Sale+OE | 100,000 | $33.73 | $3,373,240.00 | - | -4.1% | -83.7% | |
| Sep 27, 2019 | GOSS Gossamer Bio, Inc. | President &CEO | Buy | 10,000 | $16.80 | $167,980.00 | +0.2% | - | - |